BioSyndex, Inc.

Privacy Policy

Draft — not yet in effect. Counsel review in progress.

Effective date: 2026-06-02. This policy describes how BioSyndex, Inc. (“BioSyndex,” “we”) handles personal information submitted through this marketing site (biosyndex.com).

Information we collect

  • Waitlist / early access: name, work email, organization, and optional role when you submit the form.
  • Newsletter: email address when you subscribe.
  • Technical data: basic analytics (e.g. page views, device/browser metadata) via our analytics provider to understand site usage.

How we use information

  • To respond to early-access requests and operate the waitlist.
  • To send occasional newsletters or product updates if you subscribe.
  • To maintain CRM records (including with vendors such as Attio) for relationship and compliance workflows.
  • To secure the site, debug issues, and comply with law.

Sharing

We use service providers (e.g. hosting, analytics, CRM) who process data on our instructions. We do not sell your personal information.

Securities offerings and broker-dealer partner

When you use beta platform features related to private placements under Regulation D Rule 506(c), we may collect accredited-investor eligibility information (for example income, net worth, and attestations) and share it with our registered broker-dealer partner to satisfy verification and offering requirements. BioSyndex does not provide investment advice; verification and transaction execution are handled by the broker-dealer and deal documents.

We maintain audit logs of opportunity views and commitment attempts (including timestamps, verification status, and technical metadata) for compliance record-keeping.

Retention

We retain submissions as long as needed for the purposes above and as required by law. You may request deletion subject to legitimate business or legal holds.

Your choices

  • Newsletter: every marketing email includes an unsubscribe link. You may also contact us below.
  • Access / correction / deletion: email info@biosyndex.com.

International users

If you access the site from outside the United States, your information may be processed in the U.S. or other jurisdictions where we or our vendors operate.

Children

The site is not directed to children under 16.

Corporate / mailing address

[Insert BioSyndex, Inc. registered office or mailing address] — required for certain compliance regimes; replace this placeholder with your counsel-approved address.

Changes

We may update this policy; the new effective date will be posted on this page.

Contact

BioSyndex, Inc. — info@biosyndex.com

← Back to home

BioSyndexBioSyndex

BioSyndex, Inc. is a technology platform. It is not a broker-dealer, investment adviser, funding portal, exchange, alternative trading system, or transfer agent. Securities offerings referenced on this site are conducted through separate, deal-specific special purpose vehicles, with a FINRA-registered broker-dealer partner as placement agent and BioSyndex Advisors LLC (an exempt reporting adviser under Section 203(m) of the Investment Advisers Act of 1940) as SPV manager. Nothing on this site is an offer to sell or a solicitation to buy any security, or a recommendation to invest. Private placements are speculative and may result in loss of capital. Offers are made only to verified accredited investors through each offering's definitive documents.

Each deal runs through a dedicated SPV managed by BioSyndex Advisors LLC (exempt reporting adviser under Investment Advisers Act §203(m)), with a FINRA-registered broker-dealer partner as placement agent. Fees and governance are disclosed in each offering's Private Placement Memorandum and Operating Agreement.

BioSyndex, Inc. — a Katogen company

© 2026 BioSyndex, Inc.. All rights reserved.

[CONFIRM: physical mailing address]

Patent Pending

· Do Not Sell or Share